首页> 外文OA文献 >Pharmacokinetics and pharmacodynamics of insulin glargine–insulin glulisine basal-bolus and twice-daily premixed analog insulin in type 1 diabetes mellitus patients during three standardized meals

【2h】

Pharmacokinetics and pharmacodynamics of insulin glargine–insulin glulisine basal-bolus and twice-daily premixed analog insulin in type 1 diabetes mellitus patients during three standardized meals

机译：甘精胰岛素-甘草酸胰岛素基础推注和每日两次预混合的类似胰岛素在三顿标准餐中的药代动力学和药效学

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Lamos Elizabeth Mary; Younk Lisa M.; Tate Donna B.; Davis Stephen N.;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Pharmacokinetics and pharmacodynamics of insulin glargine–insulin glulisine basal-bolus and twice-daily premixed analog insulin in type 1 diabetes mellitus patients during three standardized meals [J] . Elizabeth Mary Lamos, Lisa M. Younk, Donna B. Tate, Journal of Clinical & Translational Endocrinology . 2016,第4期

机译：甘精胰岛素-甘草酸胰岛素基础推注和每日两次预混类似胰岛素在1顿3型标准餐中的药代动力学和药效学
2. Comparison of thrice-daily premixed insulin (insulin lispro premix) with basal-bolus (insulin glargine once-daily plus thrice-daily prandial insulin lispro) therapy in east Asian patients with type 2 diabetes insufficiently controlled with twice-daily premixed insulin: an open-label, randomised, controlled trial [J] . Jia Weiping, Xiao Xinhua, Ji Qiuhe, The lancet. Diabetes & endocrinology. . 2015,第4期

机译：东亚2型糖尿病患者每日两次三次预混胰岛素（赖脯胰岛素预混物）与基底推注（甘精胰岛素每天一次加三餐膳食赖脯胰岛素）的比较，每日两次预混胰岛素不能充分控制：标签，随机，对照试验
3. [Use of human insulin analogues in young patients with type 1 diabetes mellitus: Results of the RESULT observational program on the use of insulin glargine (Lantus) in combination with insulin glulisine (Apidra) as a basal-bolus regimen]. [J] . N V Efremova, L L Bolotskaya, D S Atarshchikov, Терапевтичесκий архив . 2015,第10期

机译：篇名[在年轻的1型糖尿病患者中使用人胰岛素类似物：将甘精胰岛素（Lantus）与甘精胰岛素（Apidra）联合用作基础推注方案的RESULT观察计划的结果]。
4. Switching to insulin glargine 300 U/mL from other basal insulin analogues provides less 24-hour glucose variability in hospitalized patients with type 1 diabetes [C] . V.V. Klimontov, E.A. Koroleva, O.N. Fazullina International Multiconference Bioinformatics of Genome Regulation and StructureSystems Biology . 2018

机译：从其他基础胰岛素类似物转换为甘精胰岛素300 U / mL可使住院的1型糖尿病患者的24小时葡萄糖变异性降低
5. Incidence of hypoglycemia and associated costs in Type 1and Type 2 diabetes patients treated with insulin analogs vs. human insulin: A retrospective cohort study. [D] . Shah, Hiren P. 2014

机译：使用胰岛素类似物与人胰岛素治疗的1型和2型糖尿病患者的低血糖发生率和相关费用：一项回顾性队列研究。
6. Pharmacokinetics and pharmacodynamics of insulin glargine–insulin glulisine basal-bolus and twice-daily premixed analog insulin in type 1 diabetes mellitus patients during three standardized meals [O] . Elizabeth Mary Lamos, Lisa M. Younk, Donna B. Tate, 2016

机译：甘精胰岛素–甘草胰岛素基础快速推注和每日两次预混合类似胰岛素在1顿3型标准餐中的药代动力学和药效学
7. Prandial Options to Advance Basal Insulin Glargine Therapy: Testing Lixisenatide Plus Basal Insulin Versus Insulin Glulisine Either as Basal-Plus or Basal-Bolus in Type 2 Diabetes: The GetGoal Duo-2 Trial [O] . Julio Rosenstock, Bruno Guerci, Markolf Hanefeld, 2016

机译：推进基底胰岛素沼灵治疗的折叠选项：测试Lixisenatide Plus基础胰岛素与胰岛素青氯酸盐，也可以是2型糖尿病的基础或基础推子：GetGoal Duo-2试验

Pharmacokinetics and pharmacodynamics of insulin glargine–insulin glulisine basal-bolus and twice-daily premixed analog insulin in type 1 diabetes mellitus patients during three standardized meals

著录项

引文网络

相似文献

相关主题

期刊订阅